U.S. Food and Drug Administration Center for Drug Evaluation and ResearchSkip navigation

CDER - Center for Drug Evaluation and Research Logo

Drug Information

CDER Home Site Information Comments and Feedback What's New CDER Navigation Bar

CDER ArchivesSpecific AudiencesCDER CalendarRegulatory InformationDrug InformationAbout CDERSide Navigational Buttons

Analgesia and Anti-inflammatory 
Drug Information

This web site provides information on the approval process and approved therapies for analgesia and anti-inflammatory related drugs. The Division of Anesthesia, Analgesia, and Rheumatology Products (DAARP) reviews these drugs.

Analgesics are drugs that relieve pain.

Anti-inflammatories are drugs used to reduce inflammation - the redness, heat, swelling, and increased blood flow found in infections and in many chronic non-infective diseases such as rheumatoid arthritis and gout.

FDA safety information on COX-2 selective non-steroidal anti-inflammatory drugs  (NSAIDs), including Bextra, Celebrex, Naproxen, and Vioxx are available at this web site: http://www.fda.gov/cder/drug/infopage/COX2/default.htm 

Biologic drugs are derived from living sources (such as humans, animals, and microorganisms) in contrast to conventional small molecule drugs that are chemically synthesized. Several biologics are approved for treatment of rheumatoid arthritis, including the TNF-alpha blockers Enbrel, Remicade and Humira and the IL-1 blocker Kineret. Some of the biologics are also approved for other forms of arthritis, including psoriatic arthritis, ankylosing spondylitis and polyarticular juvenile rheumatoid arthritis.

totop.gif (1525 bytes) Back to Top   Back Back to Drug Info

FDA/Center for Drug Evaluation and Research
Last Updated: December 14, 2005
Originator: OTCOM/DLIS